Viatris Eye Care
在场
Viatris Eye Care 的所有者是 Viatris.
是其中之一......
Viatris 是一家在股票代码 VTRS (US) 下上市的公司。
Viatris 在 11 个国家有直接业务。Viatris 拥有 11家子公司，其中包括 Viatris Australia、Viatris Canada 和 Viatris China。
他们在：
高管
查看带有其 8 名主要高管的组织结构图
Viatris Eye Care 搜索最多的简介
- Eric Carlson, Chief Scientific Officer
- Raegan McClain, Chief Compliance and Privacy Officer
- Marian Macsai, Chief Medical Officer
高管在Viatris变化
- Sanjeev Sethi, Chief Operating Officer, 已经离开公司 (新闻发布的2024八月7号).
- Rogerio Vivaldi已作为Director加入公司 (新闻发布的2024六月4号).
- Corinne Le Goff已作为Chief Commercial Officer加入公司 (新闻发布的2024四月16号).
创建提醒
跟踪 Viatris Eye Care 的高管变动
生物技术
Viatris 拥有 2,332 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- March Biosciences 刚刚宣布为 28 筹款数百万美元。 (公布2024十二月3号).
- Lyell Immunopharma 已收购 ImmPACT Bio (公布2024十一月29号).
- Hopo Therapeutics 刚刚宣布为 226 筹款数百万美元。 (公布2024十一月29号).
生物技术 行业的其他推荐联系人
消息
Viatris Eye Care 的最新新闻稿
- Events & Presentations - Oyster Point Pharma, Inc.
- Oyster Point Pharma Announces Board of Directors Leadership Changes and New Appointment as the Company Advances into Next Phase of Growth - Oyster Point Pharma, Inc.
- Oyster Point Pharma to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference - Oyster Point Pharma, Inc.
- Oyster Point Pharma Reports Second Quarter 2020 Financial Results and Recent Business Highlights - Oyster Point Pharma, Inc.
- News Releases - Oyster Point Pharma, Inc.
- Oyster Point Pharma to Report Second Quarter 2020 Financial Results on August 5, 2020 - Oyster Point Pharma, Inc.
- News Releases - Oyster Point Pharma, Inc.
- Oyster Point Pharma Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Oyster Point Pharma, Inc.
- Oyster Point Pharma Announces Pricing of an Upsized Offering of Common Stock - Oyster Point Pharma, Inc.
- Oyster Point Pharma Proposed Public Offering of Common Stock - Oyster Point Pharma, Inc.
- View more press releases Close
通过电子邮件
